Article
Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.
Antiviral research - 1 Aug 2006
de Castro Sonia, García-Aparicio Carlos, Van Laethem Kristel, Gago Federico, Lobatón Esther, De Clercq Erik, Balzarini Jan, Camarasa María-José, Velázquez Sonsoles
Abstract excerpt
The very first TSAO derivative that lacks the 4''-amino group at the 3'-spiro moiety (compound 3) has been prepared and the effect of this modification on the activity/resistance profile has been evaluated. This molecule proved HIV-1 specific (NNRTI-characteristic). A mixture of wild-type and V106V/A or L234L/I mutations were found in the RT of some, but not all compound 3-resistant virus strains. Compound 3 does...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
